Long-Term Treatment with Mammalian Target of Rapamycin Inhibitor Does Not Benefit Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis

Publisher： Karger

E-ISSN： 1660-2110|124|1-2|10-16

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.124, Iss.1-2, 2013-09, pp. : 10-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practical Genetics for Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c19-c30

Karger

Access to resources Recommend Favorite

Survival after Starting Renal Replacement Treatment in Patients with Autosomal Dominant Polycystic Kidney Disease: A Single-Centre 40-Year Study

By  

Nephron Clin Pract, Vol. 120, Iss. 1, 2011-12 ,pp. : c42-c47

Karger

Access to resources Recommend Favorite

Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease

By Pietrzak-Nowacka Maria   Safranow Krzysztof   Byra Elżbieta   Nowosiad Monika   Marchelek-Myśliwiec Małgorzata   Ciechanowski Kazimierz  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 8, 2010-12 ,pp. : 561-567

Informa Healthcare

Access to resources Recommend Favorite

Demographic and Clinical Characteristics of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Experience

By  

Nephron Clin Pract, Vol. 117, Iss. 3, 2010-09 ,pp. : c270-c275

Karger

Access to resources Recommend Favorite

Ultrasonic Characterization (Integrated Backscatter) of Myocardial Tissue in Patients with Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 114, Iss. 4, 2010-01 ,pp. : c288-c294

Karger

Access to resources Recommend Favorite